期刊文献+

中药外敷联合奥施康定在肺鳞癌患者癌痛治疗中的应用研究 被引量:5

Clinical Research on External Application of Chinese Herbs Combined with Oshicontin for Pain on Advanced Lung Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:观察中药外敷联合奥施康定治疗癌性疼痛的临床疗效。方法将2016年4月~2017年1月我科96例晚期肺鳞癌癌痛病员作为研究对象,随机分为2组,研究组(48例)和对照组(48例),其中研究组采用中药外敷痛处联合奥施康定,对照组只口服奥施康定。结果两组癌痛缓解的有效率无统计学差异(P>0.05),但是研究组每天口服奥施康定的剂量和不良反应均比对照组少,KPS评分改善情况高于对照组,差异有统计学意义(P<0.05)。结论:中药外敷联合奥施康定有效缓解肺癌癌痛、不良反应减少,患者的生活质量显著提高,值得临床进一步推广。 Objective:To observe the external application of Chinese herbs combined with Oshicontin for pain on lung squamous cell carcinoma.Methods:A total of 96patients were randomly divided into two groups.The observation group(48cases)re・ceived Chinese herbs combined with Oshicontin,and the controlled group(48cases)received only Oshicontin.Rsults:The total effective rate of the observation group(93.6%)was higher than that of the controlled group(91.7%).The two groups showed no statistically significant difference(P>0.05).The dosages and adverse reactions of the observation group were less than those of the controlled group,and the KPS score was higher than that of the controlled group(P<0.05).Conclusion:External application of traditional Chinese herbs combined with Oshicontin in the treatment of lung cancer pain is better,less side effects,significantly improved the quality of life of patients.
作者 孙光伟 向生霞 SUN Guangwei;XIANG Shengxia(Sichuan Integrated Chinese and Western Medicine Hospital,Chengdu Sichuan 610041,China)
出处 《四川中医》 2020年第2期100-102,共3页 Journal of Sichuan of Traditional Chinese Medicine
基金 四川省科技厅重点研发项目(编号:2017SZ0026)
关键词 中药外敷 奥施康定 肺鳞癌 癌痛 External application of traditional Chinese Oshicontin Lung squamous cell carcinoma Cancer pain
  • 相关文献

参考文献8

二级参考文献52

  • 1陈战,刘晓娟,林大富,涂永久.泰勒宁片纳肛对肛肠疾病术后镇痛效果观察[J].临床军医杂志,2004,32(4):18-19. 被引量:19
  • 2陶岚,李大鹏,陈锐深.中医中药在控制癌性疼痛中的作用[J].甘肃中医,2004,17(11):10-12. 被引量:3
  • 3CLOTFEL TER C E.Management of cancer pain[J].On-colong Nurse Forum,1999,26(1):27.
  • 4Wang XS,Mendoza TR,Gao SZ.The Chinese version of theBriefPain Inventory(sPi-C):its development and use in a study of-cancer pain[J].Pain,1996,67:407.
  • 5Wang XS,Mendoza TR,Gao SZ.The Chinese version of theBriefPain Inventory(sPi-C):its development and use in a study of-cancer pain[J].Pain.1996,67:407.
  • 6孙燕.内科肿瘤学[M].北京:人民卫生出版社,2003.994-995.
  • 7Sloan PA. The evolving role of interventional pain management in oncology[ J].J Support 0ncol,2004, 38(2):491-500,503.
  • 8Deer TR,Smith HS,Burton AW, et al. Comprehensive con- sensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain[J].Pain Physician,2011,49(14):283-312.
  • 9Christo PJ,Mazloomdoost R Interventional pain treat- ments for cancer pain[ J].Ann N Y Acad Sci,2008, 38(12):299-328.
  • 10Schug SA, Zech D, Dorr U. Canner pain management ac- cording to WHO analgesic guideline[J].J Pain Symptom Manage, 1990,48(5):27-32.

共引文献101

同被引文献68

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部